Yan Leyfman?linkedIn
Oct 19, 2025, 11:19
Yan Leyfman: Insightful Strategies Advancing the Safety and Precision of Myeloma Care
Yan Leyfman, Co-Founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Exceptional presentation by global multiple myeloma cell therapy leader Dr. Adriana Rossi (Icahn School of Medicine at Mount Sinai) on managing T-cell–directed toxicities at the 2025 Lymphoma, Leukemia & Myeloma Congress!
Insightful strategies advancing the safety and precision of myeloma care.”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England
-
Sep 10, 2026, 09:41Seunghwan Song: Hemlibra and the Science That Changed Hemophilia A Care
-
Sep 10, 2026, 09:20Mark Dawson: A Radical Rethink of Hemophilia Treatment
-
Sep 10, 2026, 07:26Carly Newton: Every Donation Helps Save Lives
-
Sep 10, 2026, 07:152023 ACR/EULAR APS Classification Criteria – APS Foundation of America
-
Sep 10, 2026, 07:03When Platelet Function Matters More Than Platelet Count – Glanzmann’s Research Foundation